Conference Coverage

CANVAS program analysis: Canagliflozin benefits patients with T2DM and poor kidney function


 

REPORTING FROM ADA 2018

SOURCE: de Zeeuw D et al. ADA 2018, Abstract 258-OR.

Next Article:

Diabetes risk may rise with work hours

Related Articles